Plant natural products represent a largely untapped resource for discovering bioactive compounds to fill the antimicrobial drug development pipeline. With approximately 2.9 million antibiotic-resistant infections resulting in more than 35,000 deaths in the United States each year , there is an urgent need to fill our dwindling antibiotic pipeline with new chemical scaffolds for optimization and clinical assessment. In the search for new antibiotics, screens of synthetic chemical libraries have ultimately failed, revealing the critical importance of exploring the biologically relevant chemical space . This is where plant natural products can play a pivotal role. Many of our most essential...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!